Literature DB >> 31522035

Urgent Surgery for Gastric Adenocarcinoma: A Study of the National Cancer Database.

Benjamin W Fisher1, Marcus Fluck1, Katelyn Young1, Mohsen Shabahang1, Joseph Blansfield1, Tania K Arora1.   

Abstract

BACKGROUND: Gastric adenocarcinoma is a leading cause of cancer death worldwide and, in the United States, can present emergently with upper GI hemorrhage, obstruction, or perforation. No large studies have examined how urgent surgery affects patient outcomes. This study examines the outcomes of urgent versus elective surgery for gastric cancer.
MATERIALS AND METHODS: Patients with gastric adenocarcinoma from the National Cancer Database from 2004 to 2015 were examined retrospectively. Patients with metastatic disease or incomplete data were excluded. Urgent surgery was defined as definitive surgery within 3 d of diagnosis. Univariate and multivariate analysis of patient factors, surgical outcomes, and oncologic data was performed. P-values <0.05 were statistically significant.
RESULTS: Of 26,116 total patients, 2964 had urgent surgery and 23,468 had elective surgery. Urgent surgery patients were significantly older, were female, were nonwhite, had higher pathologic stage, and were treated at a low-volume center. Urgent surgery was associated with decreased quality lymph node harvest (odds ratio [OR] 0.68 95% confidence interval {CI} [0.62, 0.74]), increased positive surgical margin (OR 1.48, 95% CI [1.32, 1.65]), increased 30-d mortality (OR 1.38, 95% CI [1.16, 1.65]), increased 90-d mortality (OR 1.30, 95% CI [1.14, 1.49]), and decreased overall survival (hazard ratio 1.21, 95% CI [1.15, 1.27]).
CONCLUSIONS: Urgent surgery for gastric cancer is associated with significantly worse outcomes than elective surgery. Stable patients requiring urgent surgical resection for gastric cancer may benefit from referral to a high-volume center for resection by an experienced surgeon. Patients undergoing urgent resection for gastric cancer should be referred to surgical and medical oncologists to ensure they receive appropriate adjuvant therapy and surveillance.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emergent surgery; Gastric adenocarcinoma; Gastric cancer; NCDB; National Cancer Database; Urgent surgery

Mesh:

Year:  2019        PMID: 31522035     DOI: 10.1016/j.jss.2019.07.073

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

Review 1.  Associations of Annual Hospital and Surgeon Volume with Patient Outcomes After Gastrectomy: A Systematic Review and Meta-analysis.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan
Journal:  Ann Surg Oncol       Date:  2022-09-15       Impact factor: 4.339

Review 2.  Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Authors:  Milad Ashrafizadeh; Hossein Rafiei; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2021-01-21       Impact factor: 5.722

Review 3.  Perforated gastric cancer: a critical appraisal.

Authors:  Sara Di Carlo; Marzia Franceschilli; Piero Rossi; Giuseppe Cavallaro; Maurizio Cardi; Danilo Vinci; Simone Sibio
Journal:  Discov Oncol       Date:  2021-05-15

4.  Adjuvant radiotherapy may have significant survival benefits for gastric cancer patients with 1-29 lymph nodes retrieved.

Authors:  Siyi Wu; Yuxin Chu; Qinyong Hu; Qibin Song
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.